Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Complex Assembly02:41

Protein Complex Assembly

11.5K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
11.5K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.6K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.8K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.6K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.0K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malaria Public Health Status: Global Context and Update on Gulf Cooperation Council Countries.

Advances in experimental medicine and biology·2026
Same author

Hsp70 is phosphorylated in a conserved response to DNA damage and contributes to cell cycle control.

eLife·2026
Same author

Author Correction: High-throughput discovery of fluoroprobes that recognize amyloid fibril polymorphs.

Nature chemistry·2026
Same author

Emergence of specific binding and catalysis from a designed generalist binding protein.

Nature chemistry·2026
Same author

An Optimized Route to the Syringolin Natural Products Enables Combinatorial Synthesis of Selective, Bioactive Inhibitors of the <i><i>Plasmodium falciparum</i></i> 20S Proteasome.

Journal of medicinal chemistry·2026
Same author

Survey of the human proteostasis network: the ubiquitin-proteasome system.

bioRxiv : the preprint server for biology·2026
Same journal

Mechanistic dissection of SMARCA2/4 molecular glues reveals programmable switching between DCAF16 and FBXO22.

Cell chemical biology·2026
Same journal

Beyond the veil of cell death.

Cell chemical biology·2026
Same journal

Assessment of mitochondrial lipid peroxidation in cells and zebrafish using a targeted mass spectrometry probe.

Cell chemical biology·2026
Same journal

Lysine methylation as a bidirectional switch.

Cell chemical biology·2026
Same journal

Quantitative profiling of RNA modifications enriched in non-membrane-bound cellular structures using APEX-RNA-MS.

Cell chemical biology·2026
Same journal

Mechanisms and interventions of epigenetic aging.

Cell chemical biology·2026
See all related articles

Related Experiment Video

Updated: Sep 22, 2025

Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling
09:35

Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling

Published on: April 1, 2017

14.0K

Multi-protein complexes as drug targets.

Jason E Gestwicki1

  • 1Department of Pharmaceutical Chemistry, Institute for Neurodegenerative Disease, University of California, San Francisco, CA 94158, USA.

Cell Chemical Biology
|May 20, 2022
PubMed
Summary
This summary is machine-generated.

Researchers found new drugs that block the DnaK protein, a key factor in mycobacterial infections. These compounds reduce bacterial survival and antibiotic resistance, offering a potential new treatment strategy.

More Related Videos

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry
14:58

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Published on: November 12, 2012

48.4K
The MultiBac Protein Complex Production Platform at the EMBL
13:51

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

16.1K

Related Experiment Videos

Last Updated: Sep 22, 2025

Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling
09:35

Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling

Published on: April 1, 2017

14.0K
Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry
14:58

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Published on: November 12, 2012

48.4K
The MultiBac Protein Complex Production Platform at the EMBL
13:51

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

16.1K

Area of Science:

  • Microbiology
  • Drug Discovery
  • Molecular Biology

Background:

  • Mycobacterial infections pose significant health challenges.
  • The molecular chaperone DnaK is a validated drug target for combating these infections.
  • Targeting DnaK offers a promising avenue for novel therapeutic strategies.

Purpose of the Study:

  • To identify novel inhibitors of the molecular chaperone DnaK.
  • To investigate the impact of these inhibitors on bacterial survival and antibiotic resistance.
  • To explore new therapeutic approaches for mycobacterial diseases.

Main Methods:

  • A high-throughput screening approach was employed to discover DnaK inhibitors.
  • The study focused on inhibitors disrupting cofactor-mediated activation of DnaK.
  • Bacterial survival assays and antibiotic resistance tests were conducted.

Main Results:

  • Novel inhibitors targeting DnaK's cofactor-mediated activation were identified.
  • These inhibitors significantly lowered bacterial survival under stress conditions.
  • The identified compounds demonstrated a reduction in bacterial resistance to key antibiotics.

Conclusions:

  • Inhibitors disrupting DnaK activation represent a promising class of compounds for treating mycobacterial infections.
  • These findings suggest a potential strategy to overcome antibiotic resistance in mycobacteria.
  • Targeting DnaK offers a viable approach for developing new anti-mycobacterial therapies.